Teva In-Focus: A Webinar Series For The Investment Community Focusing On Teva Pharmaceutical Industries Limited (TEVA)’s R&D Activities
12/4/2013 7:30:01 AM
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that 15 new projects have entered its development pipeline from its New Therapeutic Entities (NTE) program.
Launched one year ago, the NTE program has delivered new pipeline assets in major therapeutic areas, including:
•Innovation in the abuse deterrent delivery of opioids for pain
Help employers find you! Check out all the jobs and post your resume.
comments powered by